GT Biopharma (GTBP) had the highest return between September 1, 2017 and May 31, 2018 by a US stock, returning 2,601,940.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 9/1/2017 - 5/31/2018 | 2,601,940.82% |
Delcath Systems (DCTH) | 9/1/2017 - 5/31/2018 | 2,021,255.62% |
Avalon GloboCare (ALBT) | 9/1/2017 - 5/31/2018 | 2,017,443.86% |
Alarum Technologies (ALAR) | 9/1/2017 - 5/31/2018 | 8,290% |
SurgePays (SURG) | 9/1/2017 - 5/31/2018 | 4,164.71% |
Quantum Computing (QUBT) | 9/1/2017 - 5/31/2018 | 3,000% |
Madrigal Pharmaceuticals (MDGL) | 9/1/2017 - 5/31/2018 | 1,464.99% |
Viking Therapeutics (VKTX) | 9/1/2017 - 5/31/2018 | 851.43% |
Ryvyl (RVYL) | 9/1/2017 - 5/31/2018 | 803.01% |
Thryv (THRY) | 9/1/2017 - 5/31/2018 | 754.03% |
Gyre Therapeutics (GYRE) | 9/1/2017 - 5/31/2018 | 645.62% |
eGain (EGAN) | 9/1/2017 - 5/31/2018 | 631.43% |
MDxHealth SA ADR (MDXH) | 9/1/2017 - 5/31/2018 | 616.67% |
Applied Digital (APLD) | 9/1/2017 - 5/31/2018 | 598.57% |
TON Strategy (TONX) | 9/1/2017 - 5/31/2018 | 572.73% |
CASI Pharmaceuticals (CASI) | 9/1/2017 - 5/31/2018 | 543.75% |
Enphase Energy (ENPH) | 9/1/2017 - 5/31/2018 | 529.67% |
Turtle Beach (TBCH) | 9/1/2017 - 5/31/2018 | 516.15% |
Avalo Therapeutics (AVTX) | 9/1/2017 - 5/31/2018 | 446.05% |
Galaxy Digital (GLXY) | 9/1/2017 - 5/31/2018 | 426.38% |
Anixa Biosciences (ANIX) | 9/1/2017 - 5/31/2018 | 417.65% |
eXp World (EXPI) | 9/1/2017 - 5/31/2018 | 413.92% |
Empire Petroleum (EP) | 9/1/2017 - 5/31/2018 | 400% |
Rocket Pharmaceuticals (RCKT) | 9/1/2017 - 5/31/2018 | 367.31% |
CareDx (CDNA) | 9/1/2017 - 5/31/2018 | 364.56% |
